LENVATINIB
Clinical trials for LENVATINIB explained in plain language.
Never miss a new study
Get alerted when new LENVATINIB trials appear
Sign up with your email to follow new studies for LENVATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to stop bile duct cancer from returning after surgery
Disease control OngoingThis study tests whether giving a combination of an immunotherapy drug (toripalimab), a targeted therapy (lenvatinib), and chemotherapy (GEMOX) before surgery can improve outcomes for people with a high-risk type of bile duct cancer. The trial includes 178 patients whose cancer i…
Matched conditions: LENVATINIB
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:52 UTC
-
Can scans tell who needs surgery after liver tumor shrinks?
Knowledge-focused OngoingThis study looks back at 500 people with liver cancer that could not be removed at first. After a mix of treatments (TACE, lenvatinib, and an immunotherapy drug), their tumors shrank enough to consider surgery. Researchers want to see if using scans and patient data can help deci…
Matched conditions: LENVATINIB
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Liver cancer drug review: are new treatments better?
Knowledge-focused OngoingThis study looks back at the medical records of 2,500 liver cancer patients treated at a major hospital in Taiwan between 2019 and 2024. It focuses on people who received newer drugs like immunotherapy and targeted therapy instead of the older standard treatment. The goal is to s…
Matched conditions: LENVATINIB
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC